MODERN VIEWS ON THE PROBLEM OF AMIODARONE-INDUCED THYROID  DYSFUNCTION

dc.contributor.author	Abdikadirova T.Sh., Nasirova H.K., Trigulova R.X.
dc.date.accessioned	2026-09-16T10:57:33Z
dc.date.available	2026-09-16T10:57:33Z
dc.date.issued	2023-09
dc.identifier.issn	2181-3337
dc.identifier.uri	http://repo.tma.uz/xmlui/handle/1/5210
dc.description.abstract	This review presents various perspectives of scientists regarding the effectiveness of Amiodarone as a preferred antiarrhythmic drug commonly used for the treatment of ventricular arrhythmias and atrial fibrillation (AF). However, due to the high toxicity of Amiodarone, there is a risk of potential damage to various organs, including the liver, lungs, cornea, skin, and thyroid gland. According to the scientific literature, the most commonly observed disorders associated with Amiodarone use are subclinical hypothyroidism (18%) and overt thyrotoxicosis (15.8%), with less frequent occurrences of overt hypothyroidism (1.5%) and subclinical thyrotoxicosis (1.5%). Continuous research in this field has led to a change in the understanding of the problem and the development of new approaches to the diagnosis and treatment of these disorders	en_US
dc.language.iso	en_US	en_US
dc.publisher	O'zbekiston, Toshkent (SCIENCE AND INNOVATION) International Scientific Journal	en_US
dc.subject	Amiodarone, arrhythmia, Amiodarone-induced thyrotoxicosis, Amiodarone induced hypothyroidism.	en_US
dc.title	MODERN VIEWS ON THE PROBLEM OF AMIODARONE-INDUCED THYROID DYSFUNCTION	en_US
dc.type	Article	en_US